BMY

MKT CAP:$112B

Bristol-Myers Squibb Company

Market Cap

$112B

Healthcare·Drug Manufacturers - General·🇺🇸 United States·NYSE

Healthcare·Drug Mfg.·🇺🇸·NYSE

Stock Price

$55.57+$2.66 (+5.02%)

Jun 8, 2026

52W High $61.7352W Low $41.67

Company Details

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other...

CEO

—

IPO Date

Jan 1, 1972

Website

www.bms.com

Key Metrics TTM

Revenue

$48.5B

+1.8% YoY

Net Income

$7.3B

EPS (Diluted)

Free Cash Flow

$11.9B

Revenue / Share

$23.72

Gross Margin

68.7%

Operating Margin

25.7%

Net Margin

15.0%

FCF Margin

24.6%

P/S

2.3x

P/E

15.4x

Earnings Reports

Q2 2026

Jul 30, 2026

PENDING

Q1 2026

Apr 30, 2026

$11.5B+2.6%

FY 2025

Feb 11, 2026

$48.2B-0.2%

Q4 2025

Feb 11, 2026

$12.5B+1.3%

Q3 2025

Oct 30, 2025

$12.2B+2.8%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee